These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 21628511
1. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, Baldi P, Felgner PL, Doolan DL. Mol Cell Proteomics; 2011 Sep; 10(9):M111.007948. PubMed ID: 21628511 [Abstract] [Full Text] [Related]
2. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. Bettencourt P. Front Immunol; 2020 Sep; 11():190. PubMed ID: 32153565 [Abstract] [Full Text] [Related]
3. Antibody Biomarkers Associated with Sterile Protection Induced by Controlled Human Malaria Infection under Chloroquine Prophylaxis. Obiero JM, Campo JJ, Scholzen A, Randall A, Bijker EM, Roestenberg M, Hermsen CC, Teng A, Jain A, Davies DH, Sauerwein RW, Felgner PL. mSphere; 2019 Feb 20; 4(1):. PubMed ID: 30787114 [Abstract] [Full Text] [Related]
4. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites. Atre T, Robinson TM, Savransky T, Dutta S, Epstein JE, Bergmann-Leitner ES. Malar J; 2019 May 29; 18(1):186. PubMed ID: 31142328 [Abstract] [Full Text] [Related]
5. Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection. Peng K, Goh YS, Siau A, Franetich JF, Chia WN, Ong AS, Malleret B, Wu YY, Snounou G, Hermsen CC, Adams JH, Mazier D, Preiser PR, Sauerwein RW, Grüner AC, Rénia L. Cell Microbiol; 2016 Dec 29; 18(12):1739-1750. PubMed ID: 27130708 [Abstract] [Full Text] [Related]
6. Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naïve and malaria pre-exposed adult volunteers. Duffy FJ, Du Y, Carnes J, Epstein JE, Hoffman SL, Abdulla S, Jongo S, Mpina M, Daubenberger C, Aitchison JD, Stuart K. Malar J; 2021 Jul 09; 20(1):308. PubMed ID: 34243763 [Abstract] [Full Text] [Related]
9. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, Valdez C, Randall A, Molina D, Liang X, Freilich DA, Oloo JA, Blair PL, Aguiar JC, Baldi P, Davies DH, Felgner PL. Proteomics; 2008 Nov 09; 8(22):4680-94. PubMed ID: 18937256 [Abstract] [Full Text] [Related]
10. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study. Dobaño C, Ubillos I, Jairoce C, Gyan B, Vidal M, Jiménez A, Santano R, Dosoo D, Nhabomba AJ, Ayestaran A, Aguilar R, Williams NA, Díez-Padrisa N, Lanar D, Chauhan V, Chitnis C, Dutta S, Gaur D, Angov E, Asante KP, Owusu-Agyei S, Valim C, Gamain B, Coppel RL, Cavanagh D, Beeson JG, Campo JJ, Moncunill G. BMC Med; 2019 Aug 14; 17(1):157. PubMed ID: 31409398 [Abstract] [Full Text] [Related]
11. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines. Espinosa DA, Vega-Rodriguez J, Flores-Garcia Y, Noe AR, Muñoz C, Coleman R, Bruck T, Haney K, Stevens A, Retallack D, Allen J, Vedvick TS, Fox CB, Reed SG, Howard RF, Salman AM, Janse CJ, Khan SM, Zavala F, Gutierrez GM. Infect Immun; 2017 Feb 14; 85(2):. PubMed ID: 27895131 [Abstract] [Full Text] [Related]
14. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, Polhemus ME, Walsh DS, Yoon IK, Prosperi C, Juompan LY, Lanar DE, Krzych U, Hall BT, Ware LA, Stewart VA, Williams J, Dowler M, Nielsen RK, Hillier CJ, Giersing BK, Dubovsky F, Malkin E, Tucker K, Dubois MC, Cohen JD, Ballou WR, Heppner DG. Vaccine; 2010 Jul 12; 28(31):5135-44. PubMed ID: 19737527 [Abstract] [Full Text] [Related]
15. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate. Ntege EH, Arisue N, Ito D, Hasegawa T, Palacpac NMQ, Egwang TG, Horii T, Takashima E, Tsuboi T. Vaccine; 2016 Nov 04; 34(46):5612-5622. PubMed ID: 27692771 [Abstract] [Full Text] [Related]
16. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites. Campo JJ, Aponte JJ, Skinner J, Nakajima R, Molina DM, Liang L, Sacarlal J, Alonso PL, Crompton PD, Felgner PL, Dobaño C. Mol Cell Proteomics; 2015 Mar 04; 14(3):519-31. PubMed ID: 25547414 [Abstract] [Full Text] [Related]
18. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites. Bergmann ES, Ballou RW, Krzych U. Cell Immunol; 1997 Sep 15; 180(2):143-52. PubMed ID: 9341744 [Abstract] [Full Text] [Related]